Skip to main content

Site notifications

Notice for lorlatinib (Pfizer Australia Pty Ltd)

Active ingredients
lorlatinib
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Oncology

Help us improve this page